Abeliovich et al. make a compelling case for the promise of using gene therapy to treat Parkinson’s disease (PD) patients who possess mutations in the GBA1 gene. People interested in the clinical-translational side of biomedicine should definitely check this out!

This website uses a security service to protect against malicious bots. This page is displayed while the website verifies you are not a bot.